MICHAEL ARISA: Open Payments
NPI 1235360058 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 10 payments from 7 companies in 2025. Trend: 2023 $40 · 2024 $50 · 2025 $338
Food & beverage: $188Honoraria: $150
| Company | Payments | Amount |
|---|---|---|
| H2-Pharma, LLC | 1 | $150 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Alkermes, Inc. | 2 | $47 |
| Indivior Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: ARISTADA, ABILIFY ASIMTUFII, SUBLOCADE, COBENFY, REXULTI, Auvelity, UZEDY.
Industry payments across IN — which companies pay providers there.
